EJF Capital’s AEON Biopharma AEON Stock Holding History

EJF Capital’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-375	Closed	-$263K	–	292
2021 Q3	$263K	Hold	375	–	–	0.02%	176
2021 Q2	$260K	Buy	+375	New	+$262K	0.02%	166

Other funds holding AEON

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

EJF Capital's AEON Position: Q4 2021 in Review

EJF Capital sold out of AEON Biopharma (AEON) in Q4 2021, closing a stake of 375 shares — an estimated $263K sold.

EJF Capital first reported a position in AEON in Q2 2021 and held it in 2 quarters. The position peaked at $263K in Q3 2021. 73 funds tracked by Wall St. Rank hold AEON as of Q4 2021.

EJF Capital reported no remaining AEON Biopharma position as of Q4 2021 after selling out during the quarter.
EJF Capital sold 375 AEON Biopharma shares in Q4 2021, an estimated $263K.
EJF Capital first reported a position in AEON Biopharma in Q2 2021 and held it in 2 quarters.
EJF Capital's AEON Biopharma position peaked at $263K in Q3 2021.
73 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2021.

Based on EJF Capital's 13F filing for Q4 2021, filed 11 Feb 2022.